Biliary Neuroendocrine Tumors: A Retrospective Analysis of 28 Patients Since 1991 Abstract #2111
To read results and conclusion, please login ...
Further abstracts you may be interested in
#20 Paraneoplastic antigen Ma2 (PNMA2) auto-antibodies as biomarkers for early small intestine neuroendocrine tumors detection
#37 Gastric GIST with synchronous neuroendocrine tumor of the pancreas, Case Report and Literature Review
The occurrence of neuroendocrine tumors of the pancreas is rare, representing 1-5% of pancreatic cancers, and it is estimated that its incidence does not exceed 5 to one million. The tumors considered nonfunctioning (15-32% of pancreatic neuroendocrine tumors) are not associated with any syndrome, and are usually incidental. They have a slight predominance in males, and are more frequent in the 6th decade of life. Nonfunctioning tumors of islet cells are virtually all malignant tumors, and the treatment consists of surgical resection.